Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Pilot Study of KPL-914 in Recurrent Pericarditis

NCT03980522 is registered in ClinicalTrials.gov with Kiniksa Pharmaceuticals (UK), Ltd. as lead sponsor.

NCT NCT03980522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03980522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Pilot Study of KPL-914 in Recurrent Pericarditis
Lead sponsor
Kiniksa Pharmaceuticals (UK), Ltd.
Phase
Phase 2
Overall status
Completed
Start date
January 24, 2018
Completion date
May 17, 2019
Enrollment
26 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent pericarditis